Membrane-type metalloproteinases in tumor invasion

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 11, 1998, Pages 1195-1202

  Polette, Myriam ^a   Birembaut, Philippe ^a  

^a INSERM   (France)

Author keywords

Cancer invasion; Metalloproteinases; MT MMPs; Tumor cells

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; GELATIN; GELATINASE A; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MEMBRANE ENZYME; PROCOLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ZINC;

CANCER; CANCER INVASION; ENZYME ACTIVATION; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; REVIEW; STROMA CELL;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; SUBSTRATE SPECIFICITY;

EID: 0032212994     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00083-1     Document Type: Review

References (42)

1. [1] L.M. Matrisian, The matrix-degrading metallo-proteinases. BioEssays 14 (1992) 455-462.
2. [2] H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamolo, M. Sciki, A matrix metalloproteinase expressed on the surface of invasive tumuor cells. Nature 370 (1994) 61-65.
3. [3] H. Will, B. Hinzmann, cDNA sequence and mRNA tissue distribution of a novel matrix metalloproteinase with a potential transmembrane segment, Eur. J. Biochem. 231 (1995) 602-608.
4. [4] T. Takino, H. Sato, A. Shinagawa, M. Seiki, Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library, J. Biol. Chem. 270 (1995) 23013-23020.
5. [5] X.S. Puente, A.M. Pendas, E. Llano, G. Velasco, C. Lopez-Otin, Molecular cloning of a novel membrane-type matrix metaloproteinase from a human breast carcinoma. Cancer Res. 56 (1996) 944-949.
6. [6] P. Basset, J.P. Bellocq, C. Wolf, I. Stoll, P. Hutin, J.M. Limacher, O.L. Podhajcer, M.P. Chenard, M.C. Rio, P. Chambon, A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas, Nature 348 (1990) 61-65.
7. [7] H. Sato, T. Kinoshita, T. Takino, K. Nakayama, M. Seiki, Activation of a recombinant membrane type-1 matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2, FEBS Lett. 393 (1996) 101-104.
8. [8] J. Cao, A. Rehemtulla, W. Bahou, S. Zucker, Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain, J. Biol. Chem. 271 (1996) 30174-30180.
9. [9] Y. Okumura, H. Sato, M. Seiki, H. Kido, Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin, FEBS Lett. 402 (1997) 181-184.
10. [10] J. Cao, H. Sato, T. Takino, M. Seiki, The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation, J. Biol. Chem. 270 (1995) 801-805.
11. [11] D. Pei, S.J. Weiss, Transmemhrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelalinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271 (1996) 9135-9140.
12. [12] K. Shofuda, H. Yasumitsu, A. Nishihashi, K. Miki, K. Miyazaki, Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascuiar smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain, J. Biol. Chem. 272 (1997) 9749-9754.
13. [13] S. Matsumoto, M. Katoh, S. Saito, T. Watanabe, Y. Masuho, Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA, Biochim. Biophys. Acta 1354 (1997) 159-170.
14. [14] M. Yu, H. Sato, M. Seiki, E.W. Thompson, Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells, Cancer Res. 55 (1995) 3272-3277.
15. [15] J. Lohi, K. Lehti, J. Westermarck, V.M. Kähäri, J. Keski-Oja, Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbal 12-myristate 13-acetale, Eur. J. Biochem. 239 (1996) 239-247.
16. [16] C. Gilles, M. Polette, M. Seiki, P. Birembaut, E.W. Thompson, Implication of collagen type I-induced membrane-type I-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma, Lab. Invest. 76 (1997) 651-660.
17. [17] M. Polette, G. Gilles, V. Marchand, M. Seiki, J.M. Tournier, P. Birembaut, Induction of membrane-type matrix metalloproteinase (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin. Exp. Metastasis 15 (1997) 157-163.
18. [18] T. Kinoshita, H. Sato, T. Takino, M. Itoh, T. Akizawa, M. Seiki, Processing of a precursor of 72-kilodalton type IV collagenase/gelatmase A by a recombinant membrane - type 1 matrix metalloproteinase, Cancer Res. 56 (1996) 2535-2538.
19. [19] H. Will, S.J. Atkinson, G.S. Butler, B. Smith, G. Murphy, The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation, J. Biol. Chem. 271 (1996) 17119-17123.
20. [20] A.Y. Strongin, I. Collier, G. Bannikov, B.L. Manner, G.A. Grant, G. Goldberg, Mechanism of cell surface activation of 72-kDA type IV collagenase, J. Biol. Chem. 270 (1995) 5331-5338.
21. [21] S. Zucker, M. Drew, C. Conner, H.D. Foda, Y.A. De Clerck, K.E. Langley, W. Bahou, A.J.P. Docherty, J. Cao, Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase (MT1-MMP), J. Biol. Chem. 273 (1998) 1216-1222.
22. [22] G.S. Butler, M.J. Butler, S.J. Atkinson, H. Will, T. Tamura, S. Schade van Westrum, T. Crabbe, J. Clements, M.P. d'Ortho, G. Murphy, The TIMP-2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase, A. J. Biol. Chem. 273 (1998) 871-880.
23. [23] H. Sato, T. Takino, T. Kinoshita, K. Imai, Y. Okada, W.G. Stetler-Stevenson, M. Seiki, Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP), FEBS Lett. 385 (1996) 238-240.
24. [24] E.N. Baramova, K. Bajou, A. Remade, C. L'Hoir, H.W. Krell, U.H. Weidle, A. Noël, J.M. Foidart, Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation, FEBS Lett. 405 (1997) 157-162.
25. [25] R. Mazzieri, L. Masiero, L. Zanetta, S. Monea, M. Onislo, S. Garbisa, P. Mignatti, Control of type IV collagenase activity by components of the urokinase plasmin system: a regulatory mechanism with cell-bound reactants, EMBO J. 16 (1997) 2319-2332.
26. [26] A.Y. Lee, K.T. Akers, M. Collier, L. Li, A.Z. Eisen, J.L. Seltzer, Intracellular activation of gelalinase A (72 kDa type IV collagenase) by normal fibroblasts, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4424-4429.
27. [27] V. Knäuper, H. Will, C. Lopez-Otin, S.J. Atkinson, H. Stanton, R.M. Hembry, G. Murphy, Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J. Biol. Chem. 271 (1996) 17124-17131.
28. [28] K. Imai, E. Ohuchi, T. Aoki, H. Nomura, Y. Fujii, H. Sato, M. Seiki, Y. Okada, Membrane-type matrix metalloproteinase 1 is a gelatinolylic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2, Cancer Res. 46 (1996) 2707-2710.
29. [29] E. Ohuchi, K. Imai, Y. Fujii, H. Sato, M. Seiki, Y. Okada, Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules, J. Biol. Chem. 272 (1997) 2446-2451.
30. [30] C. Gilles, M. Polette, J. Piette, C. Munaut, E.W. Thompson, P. Birembaut, J.M. Foidart, High level of MT-MMP expression is associated with invasiveness of cervical cancer cells, Int. J. Cancer 65 (1996) 209-213.
31. [31] M. Polette, C. Gilles, S. De Bentzmann, D. Gruenert, J.M. Tonrnier, P. Birembaut, Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines, Clin. Exp. Metastasis 16 (1998) 105-112.
32. [32] H. Nakahara, L. Howard, E.W. Thompson, H. Sato, M. Seiki, Y. Yeh, W.T. Chen, Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloproteinase docking to invadopodia is required for cell invasion, Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7959-7964.
33. [33] Y. Tsunezuka, H. Kinoh, T. Takino, Y. Watanabe, Y. Okada, A. Shinagawa, H. Sato, M. Seiki, Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay, Cancer Res. 56 (1996) 5678-5683.
34. [34] H. Nomura, H. Sato, M. Seiki, M. Mai, Y. OkaJa, Expression of membrane-type metalloproteinase in human gastic carcinomas, Cancer Res. 55 (1995) 3263-3266.
35. [35] H. Ohtani, H. Motohashi, H. Sato, M. Seiki, H. Nagura, Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int. J. Cancer 68 (1996) 565-570.
36. [16] M. Tokuraku, H. Sato, S. Murakami, Y. Okada, Y. Watanabe, M. Seiki, Activation of the precursor of genatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis, Int. J. Cancer 64 (1995) 355-359.
37. [37] M. Polette, B. Nawrocki, C. Gilles, M. Seiki, H. Sato, J.M. Tournier, P. Birembaut, MT-MMP expression and localisation in human breast and lung cancers, Virchows Arch. 428 (1996) 29-35.
38. [38] B. Nawrocki, M. Polette, V. Marchand, M. Monteau, P. Gillery, J.M. Tournier, P. Birembaut, Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantitative and morphological analysis, Int. J. Cancer 72 (1997) 556-564.
39. [39] A. Okada, J.P. Bellocq, M. Rouyer, M.P. Chenard, M.C. Rio, P. Chambon, P. Basset, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 2730-2734.
40. [40] H. Ueno, H. Nakamura, M. Inoue, K. Imai, M. Moguchi, H. Sato, M. Seiki, Y. Okada, Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinomas, Cancer Res. 57 (1997) 2055-2060.
41. [41] T. Yoshizaki, H. Sato, Y. Maruyama, S. Murono, M. Furukawa, C.S. Park, M. Seiki, Increased expression of membrane type 1 matrix metalloproteinase in head and neck carcinoma, Cancer 79 (1997) 139-144.
42. [42] M. Yamamoto, S. Mohanan, R. Sawaya, G.N. Fuller, M. Seiki, H. Sato, Z.L. Golaslan, L.A. Liotta, G.L. Nicolson, J.S. Rao, Differential expression of membrane-type metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro, Cancer Res. 56 (1996) 384-392.